Journal article
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use
Abstract
BACKGROUND: Clopidogrel pretreatment before percutaneous coronary intervention (PCI) has been shown to reduce the risk of death and ischemic complications after PCI. However, the need for clopidogrel pretreatment is debated in patients receiving a glycoprotein IIb/IIIa inhibitor (GPI).
METHODS: We performed a collaborative meta-analysis of the results of 3 randomized trials of clopidogrel pretreatment: PCI-CURE, CREDO, and PCI-CLARITY. Patients …
Authors
Sabatine MS; Hamdalla HN; Mehta SR; Fox KAA; Topol EJ; Steinhubl SR; Cannon CP
Journal
American Heart Journal, Vol. 155, No. 5, pp. 910–917
Publisher
Elsevier
Publication Date
5 2008
DOI
10.1016/j.ahj.2007.11.020
ISSN
0002-8703